Smailova Dariga, Ospanov Erlan, Gazaliyeva Meruert, Kaidarova Dilyara, Shatkovskaya Oxana, Zamanbekova Zhanar, Amrenova Kuralay, Belikhina Tatyana, Adylkhanov Tasbolat, Omarbekov Ardak, Dauletyarova Marzhan, Pivina Lyudmila, Semenova Yuliya
Department of Innovations in Science, Semey Medical University, Semey, Republic of Kazakhstan.
Department of Neurology, Ophthalmology, and ENT, Semey Medical University, Semey, Republic of Kazakhstan.
Iran J Public Health. 2019 Dec;48(12):2216-2223.
The incidence and mortality from prostate cancer in most native Asian populations remain low although a gradual increase is observed over the last years.
The statistical analysis of official data on prostate cancer mortality and morbidity was performed for the whole country and for Pavlodar Region.
The increase in the incidence of prostate cancer among the population of Kazakhstan is observed, which may be attributed to the introduction of screening program based on serum PSA. Still, the crude incidence rates in Kazakhstan are below world indices. Over the last few years, the decreasing prostate cancer mortality is observed that might be influenced by early diagnosis. The age-standardized incidence rates show that the majority of prostate cancer cases occur in advanced ages (70 years and older).
More research is needed to determine the risk factors for prostate cancer, as well as ethnic and geographical trends for the population of Kazakhstan.
大多数亚洲本土人群中前列腺癌的发病率和死亡率仍然较低，尽管在过去几年中呈逐渐上升趋势。
对全国和巴甫洛达尔地区前列腺癌死亡率和发病率的官方数据进行了统计分析。
哈萨克斯坦人群中观察到前列腺癌发病率上升，这可能归因于基于血清PSA的筛查项目的引入。不过，哈萨克斯坦的粗发病率低于世界指数。在过去几年中，观察到前列腺癌死亡率下降，这可能受到早期诊断的影响。年龄标准化发病率表明，大多数前列腺癌病例发生在高龄（70岁及以上）人群中。
需要更多研究来确定哈萨克斯坦人群前列腺癌的危险因素以及种族和地理趋势。
